On July 2nd, Zibo Qianhui Biological Technology Co., LTD held the 2022 mid-year work summary meeting.

In recent years, due to the impact of COVID-19, many small and medium-sized enterprises have been greatly impacted. How to get out of difficulties and develop steadily is the concern of every enterprise leader and operator. In the severe market environment, in order to change the "crisis" into "opportunities", strive for qianhui in the second half of the year to find a way to seek development, successfully complete the established goals of the year, on the afternoon of July 2, Qianhui biological held a mid-year work summary meeting and performance sprint mobilization meeting in the second half of the year.

Chairman wang liping commeted on the important work of each department, the problems and put forward the corresponding suggestion to the problems existing in the work, in the second half of the work made specific deployment, and encourage everyone to face the outbreak of the huge change of market environment for the company full of confidence, on the basis of the existing business, To maintain long-term stable operation, seize every opportunity to continue to innovate, continue to customer demand-oriented in-depth research and development, with high-quality products and perfect after-sales service to our customers.

This era is the era of struggle, from the company's establishment in 2006 to now, Qianhui biological experience sixteen spring and autumn. 16 years of ups and downs, 16 years of days and nights, Qianhui people have harvested the fruits of today's diligent sweat, in the midst of difficulties again and again, we honed growth, never forget the original aspiration, forge ahead.

The second half of 2022 has begun. In the future, we will continue to work hard in the cyclodextrin industry, strive for innovation, and provide better products and services to customers.